Breaking
Tuesday, July 7, 2026

News

🇪🇺 EMA Page 21

Latest pharmaceutical news, drug approvals, and EMA regulatory updates

Showing 241–252 of 341 articles

High impact NewsApr 23, 2026

Reuters Pharma EU: Day 1 Highlights and Key Takeaways

general · 8 min

Dr. Elena Rossi
High impact NewsApr 23, 2026

Pharma News Today: Opioid Crisis, Drug Pricing, Supply Chain

general · 7 min

Dr. Elena Rossi
Critical impact NewsApr 23, 2026

FDA Approves Idvynso, Ascentage Pharma at ASCO 2026

general · 6 min

Dr. Elena Rossi
High impact NewsApr 22, 2026

RedHill's Opaganib Shows Promise in Neuroblastoma and Triple-Negative Breast Cancer Studies at AACR 2026

2 min

Sofia Alvarez
High impact NewsApr 22, 2026

SAB Biotherapeutics SAB-142 Shows C-Peptide Preservation in Type 1 Diabetes Phase 1 Trial

2 min

Matteo Ricci
High impact NewsApr 22, 2026

Boston Scientific Reports Strong Q1 2026 Growth with 10.9% US Sales Increase and Clinical Trial Breakthroughs

2 min

Charlotte Meyer
High impact NewsApr 22, 2026

CervoMed's Neflamapimod Shows Brain Volume Increase in Dementia with Lewy Bodies Trial at AAN 2026

2 min

Oliver Grant
High impact NewsApr 22, 2026

Celerion Secures Majority Investment from THL Partners to Expand Clinical Research Services

2 min

Dr. Amina Farouk
High impact NewsApr 22, 2026

Veristat Acquires Certara's Regulatory Writing Business to Expand European Market Services

2 min

Dr. Amina Farouk
High impact NewsApr 22, 2026

Lung Cancer Therapeutics Market to Hit $142.3 Billion by 2036 as Precision Medicine Drives 11.8% Growth

2 min

Sofia Alvarez
High impact NewsApr 22, 2026

Drug Delivery Devices Market Poised for Significant Growth Through 2032 Driven by Biologics and Regulatory Support

2 min

Sofia Alvarez
High impact NewsApr 22, 2026

Polycythemia Vera Market Transformation: 9 Companies Including Protagonist Therapeutics with Rusfertide to Enter by 2036

2 min

Charlotte Meyer